Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors
- First Posted Date
- 2022-04-14
- Last Posted Date
- 2025-06-17
- Lead Sponsor
- Peel Therapeutics Inc
- Target Recruit Count
- 65
- Registration Number
- NCT05329103
- Locations
- 🇺🇸
HonorHealth Research Institiute, Scottsdale, Arizona, United States
🇺🇸Stanford Cancer Center, Palo Alto, California, United States
🇺🇸Carolina BioOncology Institute, Huntersville, North Carolina, United States
News
No news found